Overview

PVAG-14 Pilot for Intermediate Stages Hodgkin Lymphoma

Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
A randomized phase II study of prednisone, vinblastine, doxorubicin, and gemcitabine in patients with intermediate stage Hodgkin's lymphoma
Phase:
Phase 2
Details
Lead Sponsor:
University of Cologne
Treatments:
Doxorubicin
Gemcitabine
Liposomal doxorubicin
Prednisone
Vinblastine